ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

KMK Kromek Group Plc

7.25
0.40 (5.84%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.40 5.84% 7.25 7.00 7.50 7.25 6.85 6.85 1,554,889 16:18:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Miscellaneous Metal Ores,nec 17.31M -6.1M -0.0102 -7.11 43.52M
Kromek Group Plc is listed in the Miscellaneous Metal Ores sector of the London Stock Exchange with ticker KMK. The last closing price for Kromek was 6.85p. Over the last year, Kromek shares have traded in a share price range of 3.15p to 8.55p.

Kromek currently has 600,247,000 shares in issue. The market capitalisation of Kromek is £43.52 million. Kromek has a price to earnings ratio (PE ratio) of -7.11.

Kromek Share Discussion Threads

Showing 976 to 1000 of 7250 messages
Chat Pages: Latest  50  49  48  47  46  45  44  43  42  41  40  39  Older
DateSubjectAuthorDiscuss
26/1/2017
07:35
Enjoy the ride, there will be plenty time for taking photos.
chimers
26/1/2017
07:34
..........SILENCE.
chimers
26/1/2017
07:32
Also if you bother to look you will find the stock out on loan here is .........ZERO.
chimers
26/1/2017
07:29
Chimers have you got a short position here by any chance that needs closing
toolsmoker
26/1/2017
07:24
Sounds to me like its going to be a long steady riser ?
chimers
26/1/2017
07:16
Thanks daz .so its fill your boots time
toolsmoker
26/1/2017
06:54
Many Thanks for the summary, quite frankly the Trump impact could be huge....
chrisdgb
25/1/2017
22:29
Here's a report from the presentation.


The work with the Chinese Tier 1 supplier of medical imaging equipment has required more development than previously thought. A short video was shown of the CT equipment, although it has to be said this wasn’t very useful. It did however look more or less complete but I forgot to note down the expected launch date. The contract could still be worth $159m as apparently the Chinese market for imaging equipment is rising because of the increasing number of mammograms and other procedures. A slide was shown of the CTZ equipment detecting a small early stage breast cancer, which is a big improvement on the current technology.

The need to raise so much money was to demonstrate to potential Tier 1 suppliers that the company is solvent and will remain so over the duration of 4 – 5 year agreements that could be signed.
My thought this morning was that they have raised the money because potential deals are imminent in the next year or so and Arnab said they expect to sign some.

The presentation re-iterated that they had high visibility (over 80%) of both this and next years revenues through existing contracts and like before there was nothing in analysts forecasts for potentially company making contracts for SPECT or radiation equipment (DARPA)

When questioned about his lack of contribution to the placing, Arnab said it wasn’t the right time for him. I checked the annual report and he has options over approximately 2m shares which by coincidence are also exercisable at 20p, so there is no need for him to take part. Whether he will take up these options remains to be seen of course.

On the potential for SPECT, he compared Kromek’s offering with the in house CTZ capabilities with those of the companies bought by GE and Siemens and said Kromek offered a wider range of capabilities, that would be very attractive to the other Tier 1 companies Philips and Toshiba but particularly so to the Tier 2 suppliers. Reading between the lines I fully expect a contract to be announced in the next 3 – 6 months and several by the end of the year, which ties in with the reason for raising the money.

He went over the potential for further orders from DARPA, re-iterating that an order for each city that needed the detectors would be of the order of $10m, that they remain the sole supplier and that Donald Trump’s focus on US security made this more likely to happen. The potential for ruggedized version of the detector was also huge.


Despite the need to grow into the now £50 market cap, I came away positive mainly because as I said earlier I believe further deals are inevitable.

daz
25/1/2017
19:26
True trotter but after they have let me know ive bought 300k today but lookiing to double
toolsmoker
25/1/2017
18:57
Lol.. tool. I think those that are here might want to load up first :/)
trotterstrading
25/1/2017
16:59
Can someone who goes to the meeting please update us if possible before the open tomorrow Many thanks in advance
toolsmoker
25/1/2017
14:25
Looking strong. A change in sentiment and sticky holders could see this go much higher..
trotterstrading
25/1/2017
13:45
Shoukd close at 23p before the meeting tonight back into 30s before long
toolsmoker
25/1/2017
13:39
have held since pre-float. feel shafted by this.
they need to walk the walk and stop talking the talk

losing faith in their ability to deliver on what they say they will

rochdale
25/1/2017
12:59
Amphion still with 6m shares. Last sold at about 24p.
2niffy
25/1/2017
12:51
Some very chunky buys coming in. The placing was oversubscribed, if we have an II looking to build on their placing position in the open market we should see sustained buying pressure over the coming weeks/months
trotterstrading
25/1/2017
11:25
If I remember rightly these share peeked at about 80p which equated to about 4x broker revenue forecasts, we know how accurate they turned out to be! Post funding 259m shares in issue, £12.5m rev forecast to April 2018 x4 add £20m cash gets you to 27p. Given managements track record very hard to believe will get back to peak valuation in absent of any substantial orders and evidence of management delivering on those orders, what happened to the order from China?
2niffy
25/1/2017
11:18
Ali. It's market mechanics mate. The city has walked the share price down when they got wind of large placing (selling shares to buy back later at lower price). At 20p the Mcap was a nonsense for company with over £30m in contracted sales and 85% visibility on FY expectations. The dead weight holding the share price down has now been removed. There will not be many selling at these levels as the shares went to sticky holders for the most part. I'm sure we will see big orders very soon which will see the share price re-rate.
trotterstrading
25/1/2017
11:04
nobody know where the share price will be - it does not give an advantage to pay over the current share price- im not sure i can follow the resoning abovetools please explain more- thanks
ali47fish
25/1/2017
10:42
The reason no discount is the price is so low when they started the presentations we was at almost 30p so the placing was at a 30 odd percent discount .the mkt got wind of this .we all know it will be walked back up to high 20s now i believe 28 to 30p with a few weeks
toolsmoker
25/1/2017
10:40
the offer is useless without a discount- by the time the new shares are listed the price might go over 20p- i will not take part without a decent discount and i am glad i did not participate last time either- if i am misguided can someone explain please!
ali47fish
25/1/2017
10:22
Buyers flexing their muscles now.......
chrisdgb
25/1/2017
10:20
It's in the RNS TT, you have to scroll down about 13 pages to find the table of director participation and the notes that follow. I can post if you can't find it but it will clutter the thread.
daz
25/1/2017
10:17
proactiveinvestors:

The move will allow the company to fully benefit from a step change in the market for detectors, which is adopting CZT technology pioneered by Kromek.

The company believes it could tap into a “significant” market with its products, which can be used in homeland security, medicine and industry.

However it admitted there have been times during negotiations with potential customers where questions over its ability to deliver product in large quantities has delayed or even scuppered significant supply contracts.

Boosting its balance sheet in this way should help remove roadblocks with manufacturers and government that want to buy Kromek’s products.

aishah
25/1/2017
10:10
#KMK all buys this morn. £20m cash in the bank. £36m contracted sales pipeline. New Blue Chip II's onboard. GBP/USD Ex.rate winner?bigfuture .lets see this 22p bid before close please
toolsmoker
Chat Pages: Latest  50  49  48  47  46  45  44  43  42  41  40  39  Older

Your Recent History

Delayed Upgrade Clock